| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Jan 03, 2025 | Jan 07, 2025 | Dube Michael P VP Chief Accounting Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $12.18 | $16,711 | -2.92% |
| Oct 02, 2024 | Oct 04, 2024 | Dube Michael P VP Chief Accounting Officer | Sell | Intellia Therapeutics, Inc. | NTLA | $19.01 | $38,248 | -4.10% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.